Cagrilintide
Also called cagri, cagrisema
A long-acting amylin analogue for weight loss, tested with semaglutide as CagriSema.
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.
What it is
Cagrilintide copies amylin, a hormone released together with insulin that makes you feel full. It lasts about a week. On its own it led to around 10% weight loss in a phase 2 trial; combined with semaglutide (CagriSema) the results were larger. It is not approved yet.
How it’s used
- Injected under the skin once a week, often alongside semaglutide, with slow dose increases.
Typical amounts
- Trials used 0.16 to 4.5 mg a week. CagriSema pairs 2.4 mg of cagrilintide with 2.4 mg of semaglutide.
Good to know
- Not approved; products sold now are unregulated.
- Nausea, constipation and tiredness are common at the start.
Educational information, not medical advice. Check anything you take with a doctor or pharmacist.